首页 > 最新文献

Cutaneous and Ocular Toxicology最新文献

英文 中文
Evaluation of the common skin diseases in patients with malignancies and the cutaneous side effects of cancer treatments. 评估恶性肿瘤患者的常见皮肤病以及癌症治疗的皮肤副作用。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-29 DOI: 10.1080/15569527.2024.2421570
Funda Tamer, Sheyda Gharehdaghi, Esra Adisen

Purpose: The diversity of skin diseases in patients with malignancies leads to diagnostic difficulties and complicate cancer treatment. Furthermore, the increasing use of chemotherapy drugs and novel treatment regimens raises the risk of the development of various cutaneous side effects and the need for dermatologists during cancer management. We investigated the skin diseases in patients with malignancies and the cutaneous side effects of cancer treatments.

Methods: Medical records of cancer patients evaluated in the Dermatology clinic between July 2018 and April 2023 were retrospectively reviewed.

Results: This study included 872 cancer patients, 374 females and 498 males. Acute myeloid leukaemia was the most common malignancy, followed by multiple myeloma and invasive ductal breast carcinoma. Graft versus host disease was observed in 89 (10.2%) patients after stem cell transplantation and radiodermatitis developed in 16 (1.8%) patients. Maculopapular drug eruption and hand foot syndrome were the most common cutaneous side effects of chemotherapy drugs. Capecitabine was the most common etiologic agent in hand foot syndrome. Cellulitis was the most frequent bacterial infection in cancer patients, whereas herpes zoster was the most frequent viral infection. Among the chemotherapy drugs that caused acneiform drug eruption, cetuximab and cytarabine were notable. Facial erythema was associated with cytarabine use in 27.3% of patients.

Conclusion: Identifying the common skin diseases in cancer patients and cutaneous side effects due to chemotherapy drugs may help to take preventive measures, develop specific and effective treatments, determine the most appropriate cancer treatment options, and increase patients' compliance with cancer treatment.

目的:恶性肿瘤患者皮肤疾病的多样性导致诊断困难,并使癌症治疗复杂化。此外,化疗药物和新型治疗方案的使用越来越多,增加了出现各种皮肤副作用的风险,在癌症治疗过程中需要皮肤科医生。我们对恶性肿瘤患者的皮肤病和癌症治疗的皮肤副作用进行了调查:回顾性审查了 2018 年 7 月至 2023 年 4 月期间在皮肤科门诊接受评估的癌症患者的病历:本研究共纳入872名癌症患者,其中女性374名,男性498名。急性髓性白血病是最常见的恶性肿瘤,其次是多发性骨髓瘤和浸润性乳腺导管癌。89名(10.2%)患者在干细胞移植后出现移植物抗宿主疾病,16名(1.8%)患者出现放射性皮炎。大疱性药物疹和手足综合征是化疗药物最常见的皮肤副作用。卡培他滨是手足综合征最常见的病原体。蜂窝织炎是癌症患者最常见的细菌感染,而带状疱疹则是最常见的病毒感染。在引起痤疮样药物疹的化疗药物中,西妥昔单抗和阿糖胞苷最为常见。27.3%的患者面部红斑与使用阿糖胞苷有关:结论:确定癌症患者常见的皮肤病以及化疗药物引起的皮肤副作用有助于采取预防措施、开发特异性的有效治疗方法、确定最合适的癌症治疗方案以及提高患者对癌症治疗的依从性。
{"title":"Evaluation of the common skin diseases in patients with malignancies and the cutaneous side effects of cancer treatments.","authors":"Funda Tamer, Sheyda Gharehdaghi, Esra Adisen","doi":"10.1080/15569527.2024.2421570","DOIUrl":"10.1080/15569527.2024.2421570","url":null,"abstract":"<p><strong>Purpose: </strong>The diversity of skin diseases in patients with malignancies leads to diagnostic difficulties and complicate cancer treatment. Furthermore, the increasing use of chemotherapy drugs and novel treatment regimens raises the risk of the development of various cutaneous side effects and the need for dermatologists during cancer management. We investigated the skin diseases in patients with malignancies and the cutaneous side effects of cancer treatments.</p><p><strong>Methods: </strong>Medical records of cancer patients evaluated in the Dermatology clinic between July 2018 and April 2023 were retrospectively reviewed.</p><p><strong>Results: </strong>This study included 872 cancer patients, 374 females and 498 males. Acute myeloid leukaemia was the most common malignancy, followed by multiple myeloma and invasive ductal breast carcinoma. Graft versus host disease was observed in 89 (10.2%) patients after stem cell transplantation and radiodermatitis developed in 16 (1.8%) patients. Maculopapular drug eruption and hand foot syndrome were the most common cutaneous side effects of chemotherapy drugs. Capecitabine was the most common etiologic agent in hand foot syndrome. Cellulitis was the most frequent bacterial infection in cancer patients, whereas herpes zoster was the most frequent viral infection. Among the chemotherapy drugs that caused acneiform drug eruption, cetuximab and cytarabine were notable. Facial erythema was associated with cytarabine use in 27.3% of patients.</p><p><strong>Conclusion: </strong>Identifying the common skin diseases in cancer patients and cutaneous side effects due to chemotherapy drugs may help to take preventive measures, develop specific and effective treatments, determine the most appropriate cancer treatment options, and increase patients' compliance with cancer treatment.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"363-368"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of oral isotretinoin on the inflammatory markers: can lymphocyte/HDL-C and platelet/HDL-C ratios be new indicators of inflammation in acne vulgaris patients? 口服异维A酸对炎症指标的影响:淋巴细胞/高密度脂蛋白胆固醇(HDL-C)和血小板/高密度脂蛋白胆固醇(HDL-C)比率能否成为寻常型痤疮患者炎症的新指标?
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-11-05 DOI: 10.1080/15569527.2024.2423257
Özge Zorlu, Hülya Albayrak, Sema Aytekin

Introduction: The effect of isotretinoin on inflammatory markers has been reported with conflicting results. No studies have been reported on the relationship between isotretinoin and lymphocyte/high-density lipoprotein cholesterol [HDL-C] ratio (LHR), neutrophil/HDL-C ratio (NHR), or platelet/HDL-C ratio (PHR) in acne patients.

Objectives: We aimed to investigate how isotretinoin affects the inflammatory markers, including LHR, NHR, and PHR, in acne vulgaris patients.

Methods: A total of 361 patients with moderate-to-severe acne vulgaris who received systemic isotretinoin for at least six months were included. Complete blood count and biochemical analyses, including monocyte/HDL-C ratio (MHR), NHR, LHR, PHR, neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), the aggregate index of systemic inflammation (AISI), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), obtained at the treatment onset and the end of the first, third, and sixth months of treatment were investigated.

Results: There was no significant difference in MHR and NHR levels between repeated measures. A significant increasing trend was seen in LHR and PHR (P = 0.001 and P = 0.011, respectively). HDL-C levels gradually and significantly declined during the six months (P < 0.001). Serum NLR, derived NLR, SII, SIRI, MLR, and AISI showed a significant decrease in line with clinical improvement in acne during the six months of therapy (P < 0.05).

Conclusions: Declining levels of NLR, MLR, SII, SIRI, and AISI may indicate the anti-inflammatory effects of isotretinoin on the pilosebaceous unit, whereas increasing levels of LHR and PHR may show systemic inflammatory activity of isotretinoin.

简介异维A酸对炎症指标的影响已有报道,但结果不尽相同。目前还没有关于异维A酸与痤疮患者淋巴细胞/高密度脂蛋白胆固醇[HDL-C]比率(LHR)、中性粒细胞/HDL-C比率(NHR)或血小板/HDL-C比率(PHR)之间关系的研究报告:我们旨在研究异维A酸如何影响寻常型痤疮患者的炎症指标,包括LHR、NHR和PHR:方法:共纳入 361 名接受异维A酸治疗至少六个月的中重度寻常型痤疮患者。全血细胞计数和生化分析,包括单核细胞/高密度脂蛋白胆固醇比率(MHR)、NHR、LHR、PHR、中性粒细胞/淋巴细胞比率(NLR)、单核细胞/淋巴细胞比率(MLR)、血小板/淋巴细胞比率(PLR)、全身炎症综合指数(AISI)、研究了治疗开始时以及治疗第一、第三和第六个月结束时获得的全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)。结果显示重复测量的 MHR 和 NHR 水平无明显差异。LHR和PHR呈明显上升趋势(分别为P = 0.001和P = 0.011)。在这六个月中,HDL-C 水平逐渐明显下降(P P 结论):NLR、MLR、SII、SIRI 和 AISI 水平的下降可能表明异维A酸对皮脂腺具有抗炎作用,而 LHR 和 PHR 水平的上升可能表明异维A酸具有全身炎症活性。
{"title":"Impact of oral isotretinoin on the inflammatory markers: can lymphocyte/HDL-C and platelet/HDL-C ratios be new indicators of inflammation in acne vulgaris patients?","authors":"Özge Zorlu, Hülya Albayrak, Sema Aytekin","doi":"10.1080/15569527.2024.2423257","DOIUrl":"10.1080/15569527.2024.2423257","url":null,"abstract":"<p><strong>Introduction: </strong>The effect of isotretinoin on inflammatory markers has been reported with conflicting results. No studies have been reported on the relationship between isotretinoin and lymphocyte/high-density lipoprotein cholesterol [HDL-C] ratio (LHR), neutrophil/HDL-C ratio (NHR), or platelet/HDL-C ratio (PHR) in acne patients.</p><p><strong>Objectives: </strong>We aimed to investigate how isotretinoin affects the inflammatory markers, including LHR, NHR, and PHR, in acne vulgaris patients.</p><p><strong>Methods: </strong>A total of 361 patients with moderate-to-severe acne vulgaris who received systemic isotretinoin for at least six months were included. Complete blood count and biochemical analyses, including monocyte/HDL-C ratio (MHR), NHR, LHR, PHR, neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), the aggregate index of systemic inflammation (AISI), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), obtained at the treatment onset and the end of the first, third, and sixth months of treatment were investigated.</p><p><strong>Results: </strong>There was no significant difference in MHR and NHR levels between repeated measures. A significant increasing trend was seen in LHR and PHR (<i>P</i> = 0.001 and <i>P</i> = 0.011, respectively). HDL-C levels gradually and significantly declined during the six months (<i>P</i> < 0.001). Serum NLR, derived NLR, SII, SIRI, MLR, and AISI showed a significant decrease in line with clinical improvement in acne during the six months of therapy (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Declining levels of NLR, MLR, SII, SIRI, and AISI may indicate the anti-inflammatory effects of isotretinoin on the pilosebaceous unit, whereas increasing levels of LHR and PHR may show systemic inflammatory activity of isotretinoin.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"383-389"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects on corneal endothelium of intravitreal injection of anti-VEGF drugs. 玻璃体内注射抗血管内皮生长因子药物对角膜内皮的影响。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-11-19 DOI: 10.1080/15569527.2024.2422914
Mariaelena Malvasi, Antonella Calandri, Elena Pacella, Enzo Maria Vingolo
<p><strong>Purpose: </strong>Intravitreal drug administration has become the gold standard for the treatment of many retinal diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR) and retinal vein occlusion (RVO). The frequency of this procedure has increased significantly after the introduction of anti-VEGF drugs, since the rise in the average age of the population, which is closely correlated with these diseases. In order to ensure therapeutic success in these patients with chronic retinal diseases, intravitreal treatment with anti-VEGF requires a long-term maintenance regimen with repeated administrations. For this reason today, we must consider the risks linked to complications associated with the long-term application of this therapy. Our study aims to investigate whether the intravitreal injection of anti-VEGF may lead to damage to the corneal endothelium, either directly through the administration procedure or indirectly due to the drug's toxicity. We aimed to establish a clear correlation between intravitreal drug administration and a statistically significant reduction in corneal endothelial cell count in the treated eye when compared to the untreated eye. The study also sought to assess whether different toxicities might be present between different types of drugs belonging to the same anti-VEGF family.</p><p><strong>Materials and methods: </strong>The study was conducted by examining a cohort of 133 patients suffering from different diseases: AMD, EMD and RVO. All patients underwent measurement of the endothelial count with CellChek<sup>®</sup> 20, considering the value measured at the first injection as time zero and reassessed at each subsequent treatment session. The measurement of the endothelial count was performed both on the eye under treatment (TE) and in the eye not undergoing intravitreal injection (NTE) with anti-VEGF drugs for each injection cycle. Different anti-VEGF drugs such as Bevacizumab, Ranibizumab, Aflibercept, Brolucizumab were used for intravitreal therapy. The test patients were included in a 12-month follow-up programme, in which the measurement intervals are dictated by the treatment plan.</p><p><strong>Results: </strong>The statistical analysis performed on the corneal endothelial cell counts showed that the ECD (endothelial cell density) parameter decreases with each administration of the drug. The analysis of the difference in the mean endothelial cell counts of the TE reveals that the difference in the number of endothelial cells between the first and second counts in TE is 54.00; greater than the difference in the number of cells found in NTE, which was 13.42. Both the difference between the TE and NTE cell counts are statistically significant. In the case of the TE, the <i>p</i>-value is <0.001, while in the case of the NTE the <i>p</i>-value is still significant as <0.05. The hypothesis that the different types of anti-VEGF drugs could determine the decrease in endothelial
目的:玻璃体内给药已成为治疗老年黄斑变性(AMD)、糖尿病视网膜病变(DR)和视网膜静脉阻塞(RVO)等多种视网膜疾病的金标准。抗血管内皮生长因子(VEGF)药物问世后,这种手术的频率显著增加,因为人口平均年龄的增加与这些疾病密切相关。为了确保对这些慢性视网膜疾病患者的治疗取得成功,抗血管内皮生长因子的玻璃体内治疗需要长期反复给药的维持方案。因此,我们必须考虑长期应用这种疗法所带来的并发症风险。我们的研究旨在探讨抗血管内皮生长因子(anti-VEGF)的玻璃体内注射是否会直接通过给药过程或间接由于药物的毒性导致角膜内皮损伤。我们的目标是在玻璃体内给药与角膜内皮细胞数量在统计学上显著减少之间建立明确的相关性。该研究还试图评估同属抗血管内皮生长因子家族的不同类型药物是否会产生不同的毒性:该研究对 133 名不同疾病的患者进行了检查:AMD、EMD 和 RVO。所有患者都接受了 CellChek® 20 内皮细胞计数测量,将首次注射时测量的数值视为零时间,并在随后的每次治疗中重新评估。内皮细胞计数的测量同时在接受治疗的眼睛(TE)和未接受抗血管内皮生长因子药物玻璃体内注射的眼睛(NTE)进行,每个注射周期测量一次。不同的抗血管内皮生长因子药物,如贝伐单抗、雷珠单抗、阿弗利百普、布鲁珠单抗,都被用于玻璃体内治疗。测试患者被纳入为期 12 个月的随访计划,测量间隔由治疗方案决定:对角膜内皮细胞计数进行的统计分析显示,每次用药后,ECD(内皮细胞密度)参数都会下降。对 TE 内皮细胞计数平均值差异的分析表明,TE 内皮细胞数在第一次计数和第二次计数之间的差异为 54.00;大于 NTE 内皮细胞数的差异(13.42)。TE 和 NTE 细胞计数之间的差异均具有统计学意义。就 TE 而言,由于 p 值大于 0.05,因此 p 值仍有意义):该研究表明,接受玻璃体内注射治疗的患者的角膜内皮细胞按抗血管内皮生长因子的注射次数计算有统计学意义的显著减少,这种减少与所使用的抗血管内皮生长因子类型(贝伐珠单抗、雷珠单抗、阿弗利百普和布罗鲁珠单抗)无关。
{"title":"Effects on corneal endothelium of intravitreal injection of anti-VEGF drugs.","authors":"Mariaelena Malvasi, Antonella Calandri, Elena Pacella, Enzo Maria Vingolo","doi":"10.1080/15569527.2024.2422914","DOIUrl":"10.1080/15569527.2024.2422914","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;Intravitreal drug administration has become the gold standard for the treatment of many retinal diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR) and retinal vein occlusion (RVO). The frequency of this procedure has increased significantly after the introduction of anti-VEGF drugs, since the rise in the average age of the population, which is closely correlated with these diseases. In order to ensure therapeutic success in these patients with chronic retinal diseases, intravitreal treatment with anti-VEGF requires a long-term maintenance regimen with repeated administrations. For this reason today, we must consider the risks linked to complications associated with the long-term application of this therapy. Our study aims to investigate whether the intravitreal injection of anti-VEGF may lead to damage to the corneal endothelium, either directly through the administration procedure or indirectly due to the drug's toxicity. We aimed to establish a clear correlation between intravitreal drug administration and a statistically significant reduction in corneal endothelial cell count in the treated eye when compared to the untreated eye. The study also sought to assess whether different toxicities might be present between different types of drugs belonging to the same anti-VEGF family.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;The study was conducted by examining a cohort of 133 patients suffering from different diseases: AMD, EMD and RVO. All patients underwent measurement of the endothelial count with CellChek&lt;sup&gt;®&lt;/sup&gt; 20, considering the value measured at the first injection as time zero and reassessed at each subsequent treatment session. The measurement of the endothelial count was performed both on the eye under treatment (TE) and in the eye not undergoing intravitreal injection (NTE) with anti-VEGF drugs for each injection cycle. Different anti-VEGF drugs such as Bevacizumab, Ranibizumab, Aflibercept, Brolucizumab were used for intravitreal therapy. The test patients were included in a 12-month follow-up programme, in which the measurement intervals are dictated by the treatment plan.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The statistical analysis performed on the corneal endothelial cell counts showed that the ECD (endothelial cell density) parameter decreases with each administration of the drug. The analysis of the difference in the mean endothelial cell counts of the TE reveals that the difference in the number of endothelial cells between the first and second counts in TE is 54.00; greater than the difference in the number of cells found in NTE, which was 13.42. Both the difference between the TE and NTE cell counts are statistically significant. In the case of the TE, the &lt;i&gt;p&lt;/i&gt;-value is &lt;0.001, while in the case of the NTE the &lt;i&gt;p&lt;/i&gt;-value is still significant as &lt;0.05. The hypothesis that the different types of anti-VEGF drugs could determine the decrease in endothelial","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"369-382"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nicotine acute impact on RNFL: a comparative analysis of smoking cessation aids including nicotine gum and electronic cigarettes. 尼古丁对 RNFL 的急性影响:尼古丁口香糖和电子香烟等戒烟辅助工具的比较分析。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.1080/15569527.2024.2408694
Mohammed Alhazmi, Wafa Alotaibi

Purpose: To investigate the immediate impact of nicotine consumption on Retinal Nerve Fiber Layer (RNFL) thickness in healthy young individuals, comparing nicotine gum and electronic cigarette (vaping) as delivery methods.

Materials and methods: Twenty participants underwent RNFL measurements at baseline, 30, and 60 minutes after consuming 4 mg of nicotine, based on product labeling and specifications. Measurements were obtained using optical coherence tomography (OCT) (Topcon 3D OCT-1 Maestro System). Nicotine was delivered through either nicotine gum or vaping.

Results: Both nicotine gum and vaping led to a statistically significant increase in RNFL thickness, with no significant difference between the two methods. The analysis revealed that area, time, and visit factors significantly affected RNFL scores. Stratification by smoking type (tobacco, vaping, dual) demonstrated significant effects for area, time, and visit factors, with an interaction effect among these factors.

Conclusions: The findings highlight the acute impact of nicotine intake on RNFL thickness in young healthy smokers. Researchers and clinicians should account for recent nicotine exposure when evaluating RNFL thickness, particularly within the first hour post-smoking. The observed significant effects warrant further research, especially in older or health-compromised populations, to improve clinical protocols and diagnostic evaluations across different demographics.

目的:比较尼古丁口香糖和电子香烟(vaping)两种给药方式,研究尼古丁摄入对健康年轻人视网膜神经纤维层(RNFL)厚度的直接影响:根据产品标签和规格,20 名参与者在摄入 4 毫克尼古丁后的基线、30 分钟和 60 分钟接受了视网膜神经纤维层厚度测量。测量采用光学相干断层扫描(OCT)(Topcon 3D OCT-1 Maestro 系统)。尼古丁通过尼古丁口香糖或烟雾剂输送:结果:尼古丁口香糖和吸食都会导致 RNFL 厚度出现统计学意义上的显著增加,两种方法之间没有明显差异。分析显示,面积、时间和就诊因素对 RNFL 分数有明显影响。按吸烟类型(烟草、吸食电子烟、双重)进行的分层显示,面积、时间和就诊因素对RNFL有明显影响,这些因素之间存在交互作用:结论:研究结果凸显了尼古丁摄入量对年轻健康吸烟者RNFL厚度的急性影响。研究人员和临床医生在评估 RNFL 厚度时应考虑近期尼古丁暴露,尤其是在吸烟后一小时内。观察到的重大影响值得进一步研究,尤其是在老年人或健康受损人群中,以改进不同人群的临床方案和诊断评估。
{"title":"Nicotine acute impact on RNFL: a comparative analysis of smoking cessation aids including nicotine gum and electronic cigarettes.","authors":"Mohammed Alhazmi, Wafa Alotaibi","doi":"10.1080/15569527.2024.2408694","DOIUrl":"10.1080/15569527.2024.2408694","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the immediate impact of nicotine consumption on Retinal Nerve Fiber Layer (RNFL) thickness in healthy young individuals, comparing nicotine gum and electronic cigarette (vaping) as delivery methods.</p><p><strong>Materials and methods: </strong>Twenty participants underwent RNFL measurements at baseline, 30, and 60 minutes after consuming 4 mg of nicotine, based on product labeling and specifications. Measurements were obtained using optical coherence tomography (OCT) (Topcon 3D OCT-1 Maestro System). Nicotine was delivered through either nicotine gum or vaping.</p><p><strong>Results: </strong>Both nicotine gum and vaping led to a statistically significant increase in RNFL thickness, with no significant difference between the two methods. The analysis revealed that area, time, and visit factors significantly affected RNFL scores. Stratification by smoking type (tobacco, vaping, dual) demonstrated significant effects for area, time, and visit factors, with an interaction effect among these factors.</p><p><strong>Conclusions: </strong>The findings highlight the acute impact of nicotine intake on RNFL thickness in young healthy smokers. Researchers and clinicians should account for recent nicotine exposure when evaluating RNFL thickness, particularly within the first hour post-smoking. The observed significant effects warrant further research, especially in older or health-compromised populations, to improve clinical protocols and diagnostic evaluations across different demographics.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"341-346"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142343346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the early effects of the first-dose administration of the Sinovac vaccine on the retina, choroid, and optic disc using optical coherence tomography (OCT) and OCT-angiography. 使用光学相干断层扫描(OCT)和 OCT 血管造影术评估第一剂 Sinovac 疫苗对视网膜、脉络膜和视盘的早期影响。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-09 DOI: 10.1080/15569527.2024.2408683
Yelda Yildiz Tasci, Mehmet Icoz, Sule Gokcek Gurturk Icoz, Ozge Saritas, Mucella Arikan Yorgun, Yasin Toklu

Aim: To determine the effects of the first-dose administration of the Sinovac vaccine on the retina, choroid, and optic disc in healthy participants.

Methods: This prospective design study was conducted with 27 healthy healthcare workers who received the first dose of Sinovac vaccine and 25 healthy controls who were not vaccinated. In the vaccinated group, ophthalmological examinations and measurements were performed before vaccination and one week and one month after vaccination. Subfoveal, nasal, and temporal choroidal thicknesses (CTs), retinal nerve fiber layer (RNFL) thickness, and macular thickness (MT) were determined using spectral domain-optical coherence tomography at all visits. Superficial, deep, and peripapillary radial capillary plexus (superficial capillary plexus, deep capillary plexus (DCP), and radial peripapillary capillary, respectively), choriocapillaris vascular density, and foveal avascular zone parameters were measured on optical coherence tomography-angiography (OCT-A).

Results: No significant difference was detected between the two groups in terms of the parameters measured by OCT and OCT-A (p > 0.05 for all). The CT values measured in all quadrants were significantly higher at the first week after vaccination (p < 0.05 for all), and they returned to their pre-vaccination values at the first month post-vaccination measurement (p > 0.05 for all). Concerning the RNFL and MT values, there was no significant difference between the pre-vaccination and post-vaccination first-week measurements (p > 0.05 for all), but a statistically significant increase was detected in the post-vaccination first-month MT and RNFL measurements (p < 0.05 for all). Only the decreases in the foveal DCP and choriocapillaris vascular density values were significant at the first week after vaccination (p < 0.05 for all).

Conclusion: The early changes detected after vaccination in this study suggest the possibility that autoimmune, vascular, and inflammatory diseases may simultaneously emerge in the early post-vaccination period or may be triggered after vaccination, or that the vaccine may unmask these diseases.

目的:确定首剂接种 Sinovac 疫苗对健康参与者视网膜、脉络膜和视盘的影响:这项前瞻性设计研究的对象是接种第一剂 Sinovac 疫苗的 27 名健康医护人员和未接种疫苗的 25 名健康对照者。接种组在接种前、接种后一周和一个月分别进行了眼科检查和测量。在所有检查中都使用光谱域光学相干断层扫描测定了眼底、鼻腔和颞部脉络膜厚度(CT)、视网膜神经纤维层厚度(RNFL)和黄斑厚度(MT)。光学相干断层扫描-血管造影(OCT-A)测量了浅层、深层和桡侧毛细血管丛(分别为浅层毛细血管丛、深层毛细血管丛(DCP)和桡侧毛细血管丛)、绒毛膜血管密度和眼窝无血管区参数:结果:两组的 OCT 和 OCT-A 测量参数无明显差异(均 p > 0.05)。接种疫苗后第一周,所有象限的 CT 值均明显升高(P 均 > 0.05)。至于 RNFL 和 MT 值,接种前和接种后第一周的测量值之间没有明显差异(均 p > 0.05),但在接种后第一个月的 MT 和 RNFL 测量值中发现了统计学意义上的显著增加(p p 结论):本研究在接种疫苗后发现的早期变化表明,自身免疫性、血管性和炎症性疾病可能在接种疫苗后的早期同时出现,或在接种疫苗后诱发,或疫苗可能掩盖这些疾病。
{"title":"Evaluation of the early effects of the first-dose administration of the Sinovac vaccine on the retina, choroid, and optic disc using optical coherence tomography (OCT) and OCT-angiography.","authors":"Yelda Yildiz Tasci, Mehmet Icoz, Sule Gokcek Gurturk Icoz, Ozge Saritas, Mucella Arikan Yorgun, Yasin Toklu","doi":"10.1080/15569527.2024.2408683","DOIUrl":"10.1080/15569527.2024.2408683","url":null,"abstract":"<p><strong>Aim: </strong>To determine the effects of the first-dose administration of the Sinovac vaccine on the retina, choroid, and optic disc in healthy participants.</p><p><strong>Methods: </strong>This prospective design study was conducted with 27 healthy healthcare workers who received the first dose of Sinovac vaccine and 25 healthy controls who were not vaccinated. In the vaccinated group, ophthalmological examinations and measurements were performed before vaccination and one week and one month after vaccination. Subfoveal, nasal, and temporal choroidal thicknesses (CTs), retinal nerve fiber layer (RNFL) thickness, and macular thickness (MT) were determined using spectral domain-optical coherence tomography at all visits. Superficial, deep, and peripapillary radial capillary plexus (superficial capillary plexus, deep capillary plexus (DCP), and radial peripapillary capillary, respectively), choriocapillaris vascular density, and foveal avascular zone parameters were measured on optical coherence tomography-angiography (OCT-A).</p><p><strong>Results: </strong>No significant difference was detected between the two groups in terms of the parameters measured by OCT and OCT-A (<i>p</i> > 0.05 for all). The CT values measured in all quadrants were significantly higher at the first week after vaccination (<i>p</i> < 0.05 for all), and they returned to their pre-vaccination values at the first month post-vaccination measurement (<i>p</i> > 0.05 for all). Concerning the RNFL and MT values, there was no significant difference between the pre-vaccination and post-vaccination first-week measurements (<i>p</i> > 0.05 for all), but a statistically significant increase was detected in the post-vaccination first-month MT and RNFL measurements (<i>p</i> < 0.05 for all). Only the decreases in the foveal DCP and choriocapillaris vascular density values were significant at the first week after vaccination (<i>p</i> < 0.05 for all).</p><p><strong>Conclusion: </strong>The early changes detected after vaccination in this study suggest the possibility that autoimmune, vascular, and inflammatory diseases may simultaneously emerge in the early post-vaccination period or may be triggered after vaccination, or that the vaccine may unmask these diseases.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"328-334"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal structural changes in inactive thyroid eye disease: a cross-sectional analysis of the choroidal vascularity index. 非活动性甲状腺眼病的脉络膜结构变化:脉络膜血管指数的横断面分析。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-14 DOI: 10.1080/15569527.2024.2412138
Serhat Ermiş, Ece Özal, Fatma Savur, Murat Karapapak

Objective: In this study, we aimed to compare choroidal vascular changes using the Choroidal Vascularity Index (CVI) between patients with inactive Thyroid Eye Disease (iTED) and healthy individuals, and to assess the relationship between CVI and choroidal thickness (CT), smoking history, and clinical parameters.

Methods: In this cross-sectional observational study, the eyes of 30 patients aged 18 to 45 with iTED were compared with the randomly selected eyes of 35 age and gender-matched healthy control individuals. Optical coherence tomography (OCT) scans were taken from all participants. The images were binarized using the ImageJ software, and the total choroidal area (TCA) and luminal area (LA) were measured. The ratio of the LA to the TCA was used to calculate the CVI. The relationships between these measurement parameters and clinical activity score (CAS), exophthalmometry, smoking status, and other clinical parameters were examined.

Results: In the iTED group, CT and CVI values were significantly higher compared to the control group (p < 0.001, p = 0.029). No significant effect of smoking on choroidal parameters was detected in the iTED group. Additionally, there was no statistical correlation between choroidal parameters and either exophthalmometry or CAS (p > 0.05). In the multivariate regression analysis, it was determined that CT showed a significant relationship with thyroid stimulating immunoglobulin (TSI) (p = 0.003).

Conclusions: This study found that CT and CVI were increased in the eyes of patients with iTED compared to healthy controls. The history of smoking did not appear to have any effect on CT and CVI in iTED patients.

研究目的本研究旨在使用脉络膜血管指数(CVI)比较非活动性甲状腺眼病(iTED)患者与健康人之间的脉络膜血管变化,并评估CVI与脉络膜厚度(CT)、吸烟史和临床参数之间的关系:在这项横断面观察性研究中,30 名 18 至 45 岁的 iTED 患者的眼睛与随机选取的 35 名年龄和性别匹配的健康对照者的眼睛进行了比较。所有参与者都进行了光学相干断层扫描(OCT)。使用 ImageJ 软件对图像进行二值化处理,并测量脉络膜总面积(TCA)和管腔面积(LA)。LA 与 TCA 之比用于计算 CVI。研究了这些测量参数与临床活动评分(CAS)、眼外伤测量、吸烟状况和其他临床参数之间的关系:在 iTED 组中,CT 和 CVI 值明显高于对照组(P 0.05)。在多变量回归分析中,CT 与促甲状腺免疫球蛋白(TSI)有显著关系(P = 0.003):本研究发现,与健康对照组相比,iTED 患者眼部的 CT 和 CVI 均有所增加。吸烟史似乎对 iTED 患者的 CT 和 CVI 没有任何影响。
{"title":"Choroidal structural changes in inactive thyroid eye disease: a cross-sectional analysis of the choroidal vascularity index.","authors":"Serhat Ermiş, Ece Özal, Fatma Savur, Murat Karapapak","doi":"10.1080/15569527.2024.2412138","DOIUrl":"10.1080/15569527.2024.2412138","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we aimed to compare choroidal vascular changes using the Choroidal Vascularity Index (CVI) between patients with inactive Thyroid Eye Disease (iTED) and healthy individuals, and to assess the relationship between CVI and choroidal thickness (CT), smoking history, and clinical parameters.</p><p><strong>Methods: </strong>In this cross-sectional observational study, the eyes of 30 patients aged 18 to 45 with iTED were compared with the randomly selected eyes of 35 age and gender-matched healthy control individuals. Optical coherence tomography (OCT) scans were taken from all participants. The images were binarized using the ImageJ software, and the total choroidal area (TCA) and luminal area (LA) were measured. The ratio of the LA to the TCA was used to calculate the CVI. The relationships between these measurement parameters and clinical activity score (CAS), exophthalmometry, smoking status, and other clinical parameters were examined.</p><p><strong>Results: </strong>In the iTED group, CT and CVI values were significantly higher compared to the control group (p < 0.001, p = 0.029). No significant effect of smoking on choroidal parameters was detected in the iTED group. Additionally, there was no statistical correlation between choroidal parameters and either exophthalmometry or CAS (p > 0.05). In the multivariate regression analysis, it was determined that CT showed a significant relationship with thyroid stimulating immunoglobulin (TSI) (p = 0.003).</p><p><strong>Conclusions: </strong>This study found that CT and CVI were increased in the eyes of patients with iTED compared to healthy controls. The history of smoking did not appear to have any effect on CT and CVI in iTED patients.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"356-362"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Independent risk factor of drug eruption in immune checkpoint inhibitors treated liver cancer patients: high systemic immune-inflammation index. 接受免疫检查点抑制剂治疗的肝癌患者发生药物爆发的独立风险因素:高全身免疫炎症指数。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-24 DOI: 10.1080/15569527.2024.2387597
Hong Yiyong, Huang Ying, Li Xiaodie, Zhu Lin, Zheng Yue, Gong Zijian

Purpose: The clinical application of immune checkpoint inhibitors (ICIs) has significantly improved the prognosis of liver cancer patients. However, drug eruption associated with ICI monotherapy or combination therapy not only impacts the quality of life and treatment progress of liver cancer patients but also poses a potential threat to their lives. The study aims to investigate the risk factors of drug eruption in liver cancer patients undergoing ICIs in real-world settings.

Methods: We retrospectively collected data from liver cancer patients who underwent ICI therapies at the Third Affiliated Hospital of Sun Yat-sen University between 2021 and 2022. A propensity score matching (PSM) method was employed to match 31 liver cancer patients with ICI-related drug eruption (drug eruption group) to 228 liver cancer patients without immune-related adverse reactions (control group) in a 1:2 ratio, creating two groups of patients with comparable baseline characteristics. Subsequently, logistic regression analysis was then conducted to analyze the clinical risk factors associated with drug eruption caused by ICIs.

Results: Before PSM, there were statistically significant differences between the drug eruption group (31 cases) and the control group (228 cases) in two variables: Child-Pugh liver function classification and presence of vascular invasion (both p < 0.05). However, after PSM, no statistically significant differences were found in the clinical variables between the drug eruption group (28 cases) and the control group (52 cases). Univariate analysis revealed significantly higher levels of aspartate amino-transferase, alanine aminotransferase, glutamyl transpeptidase, and systemic immune-inflammation index (SII) and a significantly lower rate of liver cancer resection surgery before immunotherapy in liver cancer patients with drug eruption compared to the control group (p < 0.05). Multivariate analysis indicated that an elevated SII level before immunotherapy was significantly associated with the occurrence of drug eruption in liver cancer patients treated with ICIs (p < 0.05). The predictive performance of SII before immunotherapy in liver cancer patients for ICI-related drug eruption yielded an area under the receiver operator characteristic curve of 0.852, with a critical value of 749.189. Sensitivity and specificity were determined as 85.7% and 75%, respectively (p < 0.05).

Conclusions: Elevated systemic immune-inflammation index is identified as a risk factor for drug eruption occurrence in liver cancer patients treated with ICI therapies.

目的:免疫检查点抑制剂(ICIs)的临床应用大大改善了肝癌患者的预后。然而,与 ICI 单药或联合治疗相关的药物喷发不仅影响肝癌患者的生活质量和治疗进展,还对其生命构成潜在威胁。本研究旨在调查在真实世界环境中接受 ICIs 治疗的肝癌患者发生药物过敏的风险因素:我们回顾性地收集了2021年至2022年间在中山大学附属第三医院接受ICI治疗的肝癌患者的数据。采用倾向得分匹配法(PSM),将31例发生ICI相关药物不良反应的肝癌患者(药物不良反应组)与228例未发生免疫相关不良反应的肝癌患者(对照组)按1:2的比例进行匹配,形成两组基线特征具有可比性的患者。然后,进行逻辑回归分析,分析与 ICIs 引起药物过敏相关的临床风险因素:在 PSM 之前,药物糜烂组(31 例)与对照组(228 例)在两个变量上存在显著统计学差异:Child-Pugh肝功能分级和是否存在血管侵犯(均为p p p p 结论:药物糜烂组(31例)与对照组(228例)在 PSM前在两个变量上存在统计学差异:全身免疫炎症指数升高是接受 ICI 治疗的肝癌患者发生药物性肝癌的危险因素。
{"title":"Independent risk factor of drug eruption in immune checkpoint inhibitors treated liver cancer patients: high systemic immune-inflammation index.","authors":"Hong Yiyong, Huang Ying, Li Xiaodie, Zhu Lin, Zheng Yue, Gong Zijian","doi":"10.1080/15569527.2024.2387597","DOIUrl":"10.1080/15569527.2024.2387597","url":null,"abstract":"<p><strong>Purpose: </strong>The clinical application of immune checkpoint inhibitors (ICIs) has significantly improved the prognosis of liver cancer patients. However, drug eruption associated with ICI monotherapy or combination therapy not only impacts the quality of life and treatment progress of liver cancer patients but also poses a potential threat to their lives. The study aims to investigate the risk factors of drug eruption in liver cancer patients undergoing ICIs in real-world settings.</p><p><strong>Methods: </strong>We retrospectively collected data from liver cancer patients who underwent ICI therapies at the Third Affiliated Hospital of Sun Yat-sen University between 2021 and 2022. A propensity score matching (PSM) method was employed to match 31 liver cancer patients with ICI-related drug eruption (drug eruption group) to 228 liver cancer patients without immune-related adverse reactions (control group) in a 1:2 ratio, creating two groups of patients with comparable baseline characteristics. Subsequently, logistic regression analysis was then conducted to analyze the clinical risk factors associated with drug eruption caused by ICIs.</p><p><strong>Results: </strong>Before PSM, there were statistically significant differences between the drug eruption group (31 cases) and the control group (228 cases) in two variables: Child-Pugh liver function classification and presence of vascular invasion (both <i>p</i> < 0.05). However, after PSM, no statistically significant differences were found in the clinical variables between the drug eruption group (28 cases) and the control group (52 cases). Univariate analysis revealed significantly higher levels of aspartate amino-transferase, alanine aminotransferase, glutamyl transpeptidase, and systemic immune-inflammation index (SII) and a significantly lower rate of liver cancer resection surgery before immunotherapy in liver cancer patients with drug eruption compared to the control group (<i>p</i> < 0.05). Multivariate analysis indicated that an elevated SII level before immunotherapy was significantly associated with the occurrence of drug eruption in liver cancer patients treated with ICIs (<i>p</i> < 0.05). The predictive performance of SII before immunotherapy in liver cancer patients for ICI-related drug eruption yielded an area under the receiver operator characteristic curve of 0.852, with a critical value of 749.189. Sensitivity and specificity were determined as 85.7% and 75%, respectively (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Elevated systemic immune-inflammation index is identified as a risk factor for drug eruption occurrence in liver cancer patients treated with ICI therapies.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"258-263"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142046450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of electronic cigarette smoking on retinal nerve fiber layer, ganglion cell layer, inner plexiform layer, and choroidal thickness. 吸电子烟对视网膜神经纤维层、神经节细胞层、内丛状层和脉络膜厚度的影响。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-11-05 DOI: 10.1080/15569527.2024.2423265
Dharshini Balasubaramaniam, Yi Wen Lim, Shamala Retnasabapathy, Fazilawati A Qamarruddin, Sujaya Singh

Purpose: To compare the thickness of the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid in healthy electronic cigarette smokers and non-smokers using spectral domain optical coherence tomography (SD-OCT).

Material and method: 25 healthy electronic cigarette smokers and 25 age- and gender-matched healthy non-smokers were included in the study. RNFL, GCL, IPL and choroidal thickness were measured by SD-OCT using an automated programme. After normality tests, an independent sample t-test was used to analyse the differences in RNFL, GCL, IPL, and choroidal thickness values between the groups.

Results: The mean age of electronic cigarette smokers and non-smokers was 33.68 and 33.64 years, respectively. The mean smoking history was 6.6 years (range 5-8 years). Most of the participants smoked 2-5 ml of e-liquid per day (52%), while 36% smoked more than 5 ml and 12% smoked less than 2 ml per day. The mean intraocular pressure in the electronic cigarette smoker group was 15.0 mmHg, while the non-smoker group was 15.32 mmHg. The mean axial length in the electronic cigarette smoker group and non-smoker group was 23.36 and 23.63 mm, respectively. No significant difference was observed regarding RNFL, GCL, IPL or choroidal thickness between both groups.

Conclusion: The thickness of the RNFL, GCL, IPL, and choroid was found to be similar in both the healthy electronic cigarette smokers and non-smokers groups.

目的:使用光谱域光学相干断层扫描(SD-OCT)比较健康电子烟吸烟者和非吸烟者的视网膜神经纤维层(RNFL)、神经节细胞层(GCL)、内丛状层(IPL)和脉络膜的厚度。使用自动程序通过 SD-OCT 测量 RNFL、GCL、IPL 和脉络膜厚度。经过正态性检验后,采用独立样本 t 检验分析各组间 RNFL、GCL、IPL 和脉络膜厚度值的差异:电子烟吸烟者和非吸烟者的平均年龄分别为 33.68 岁和 33.64 岁。平均吸烟史为 6.6 年(5-8 年不等)。大多数参与者(52%)每天吸 2-5 毫升电子烟液,36% 吸 5 毫升以上,12% 吸 2 毫升以下。电子烟吸食者组的平均眼压为 15.0 毫米汞柱,而非吸食者组为 15.32 毫米汞柱。电子烟吸烟者组和非吸烟者组的平均眼轴长度分别为 23.36 毫米和 23.63 毫米。两组的 RNFL、GCL、IPL 或脉络膜厚度均无明显差异:结论:健康的电子烟吸烟者组和非吸烟者组的 RNFL、GCL、IPL 和脉络膜厚度相似。
{"title":"The effects of electronic cigarette smoking on retinal nerve fiber layer, ganglion cell layer, inner plexiform layer, and choroidal thickness.","authors":"Dharshini Balasubaramaniam, Yi Wen Lim, Shamala Retnasabapathy, Fazilawati A Qamarruddin, Sujaya Singh","doi":"10.1080/15569527.2024.2423265","DOIUrl":"10.1080/15569527.2024.2423265","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the thickness of the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid in healthy electronic cigarette smokers and non-smokers using spectral domain optical coherence tomography (SD-OCT).</p><p><strong>Material and method: </strong>25 healthy electronic cigarette smokers and 25 age- and gender-matched healthy non-smokers were included in the study. RNFL, GCL, IPL and choroidal thickness were measured by SD-OCT using an automated programme. After normality tests, an independent sample <i>t</i>-test was used to analyse the differences in RNFL, GCL, IPL, and choroidal thickness values between the groups.</p><p><strong>Results: </strong>The mean age of electronic cigarette smokers and non-smokers was 33.68 and 33.64 years, respectively. The mean smoking history was 6.6 years (range 5-8 years). Most of the participants smoked 2-5 ml of e-liquid per day (52%), while 36% smoked more than 5 ml and 12% smoked less than 2 ml per day. The mean intraocular pressure in the electronic cigarette smoker group was 15.0 mmHg, while the non-smoker group was 15.32 mmHg. The mean axial length in the electronic cigarette smoker group and non-smoker group was 23.36 and 23.63 mm, respectively. No significant difference was observed regarding RNFL, GCL, IPL or choroidal thickness between both groups.</p><p><strong>Conclusion: </strong>The thickness of the RNFL, GCL, IPL, and choroid was found to be similar in both the healthy electronic cigarette smokers and non-smokers groups.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"390-395"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa. 阿达木单抗治疗对化脓性扁平湿疹患者炎症和血液指标的影响
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-11 DOI: 10.1080/15569527.2024.2387595
Kadir Kaya, Özlem Gevher

Objective: Hidradenitis suppurativa (HS), a chronic inflammatory disease that typically manifests after puberty, is characterised by painful nodules, abscesses, draining sinus tracts, and scars in areas rich in apocrine glands such as the axillary and inguinal regions. In recent years, blood-based biomarkers such as the Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR), Monocyte/Lymphocyte Ratio (MLR), Mean Platelet Volume (MPV), Systemic Immune-Inflammation Index (SII) and Pan-Immune-Inflammation Value (PIV) have been used as significant indicators of systemic inflammation. While there are few studies evaluating these biomarkers in HS, the response of these markers to treatment has only been assessed in one study to date. Our study aims to investigate the effect of adalimumab treatment on blood-based systemic inflammation biomarkers in HS, where inflammation plays a significant role.

Methods: The study included 42 adult patients who received adalimumab treatment at our dermatology and venereology clinic between January 2020 and January 2023. Medical records for complete blood count results of the patients were retrospectively reviewed. All systemic inflammation-based biomarkers were calculated from the absolute values of the complete blood count. The SII was calculated with the following formula: (neutrophil count × platelet count/lymphocyte count). The PIV was calculated as follows: (neutrophil count × platelet count × monocyte count/lymphocyte count). Values before the treatment and at the 12th week of treatment were compared.

Results: When the changes in the inflammatory parameters of the patients were examined, it was found that NLR (2.13 ± 0.87 vs 2.26 ± 1.12), PLR (111.01 ± 39.89 vs 99.43 ± 35.34), MLR (0.27 ± 0.11 vs 0.28 ± 0.12), MPV (9.59 ± 0.71 vs 9.70 ± 0.79), SII (680.79 ± 330.18 vs 687.89 ± 442.66), and PIV (552.02 ± 330.71 vs 605.05 ± 415.96) values did not change statistically significantly after treatment (p > 0.05). While there was a significant decrease in platelet count compared to before treatment, no statistically significant difference was found in the other evaluated blood cells.

Conclusion: Adalimumab treatment has not had a significant effect on systemic inflammation markers in HS, an inflammatory disease. More studies are needed to evaluate the effect of adalimumab on these markers in HS.

目的:化脓性扁平湿疹(HS)是一种慢性炎症性疾病,通常在青春期后发病,其特征是在腋窝和腹股沟等分泌腺丰富的部位出现疼痛性结节、脓肿、引流窦道和疤痕。近年来,中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)、单核细胞/淋巴细胞比值(MLR)、平均血小板体积(MPV)、全身免疫炎症指数(SII)和泛免疫炎症值(PIV)等基于血液的生物标志物已被用作全身炎症的重要指标。虽然评估 HS 中这些生物标志物的研究不多,但迄今为止只有一项研究评估了这些标志物对治疗的反应。我们的研究旨在探讨阿达木单抗治疗对HS血液系统炎症生物标志物的影响,因为炎症在HS中起着重要作用:研究纳入了2020年1月至2023年1月期间在我院皮肤病与性病诊所接受阿达木单抗治疗的42名成年患者。对患者的全血细胞计数结果的医疗记录进行了回顾性审查。所有以全身炎症为基础的生物标志物都是根据全血细胞计数的绝对值计算得出的。SII 用以下公式计算:(中性粒细胞计数 x 血小板计数/淋巴细胞计数)。PIV 的计算公式如下(中性粒细胞计数 x 血小板计数 x 单核细胞计数/淋巴细胞计数)。比较治疗前和治疗第 12 周时的数值:检查患者炎症参数的变化时发现,NLR(2,13 ± 0,87 vs 2,26 ± 1,12)、PLR(111,01 ± 39,89 vs 99,43 ± 35,34)、MLR(0,27 ± 0,11 vs 0,28 ± 0、12)、MPV(9,59 ± 0,71 vs 9,70 ± 0,79)、SII(680,79 ± 330,18 vs 687,89 ± 442,66)和 PIV(552,02 ± 330,71 vs 605,05 ± 415,96)值在治疗后没有显著的统计学变化(P > 0.05).与治疗前相比,血小板数量明显减少,但其他被评估的血细胞在统计学上没有明显差异:结论:阿达木单抗治疗对HS这种炎症性疾病的全身炎症指标没有明显影响。结论:阿达木单抗治疗对HS这种炎症性疾病的全身炎症指标没有明显影响,还需要更多研究来评估阿达木单抗对HS这些指标的影响。
{"title":"Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa.","authors":"Kadir Kaya, Özlem Gevher","doi":"10.1080/15569527.2024.2387595","DOIUrl":"10.1080/15569527.2024.2387595","url":null,"abstract":"<p><strong>Objective: </strong>Hidradenitis suppurativa (HS), a chronic inflammatory disease that typically manifests after puberty, is characterised by painful nodules, abscesses, draining sinus tracts, and scars in areas rich in apocrine glands such as the axillary and inguinal regions. In recent years, blood-based biomarkers such as the Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR), Monocyte/Lymphocyte Ratio (MLR), Mean Platelet Volume (MPV), Systemic Immune-Inflammation Index (SII) and Pan-Immune-Inflammation Value (PIV) have been used as significant indicators of systemic inflammation. While there are few studies evaluating these biomarkers in HS, the response of these markers to treatment has only been assessed in one study to date. Our study aims to investigate the effect of adalimumab treatment on blood-based systemic inflammation biomarkers in HS, where inflammation plays a significant role.</p><p><strong>Methods: </strong>The study included 42 adult patients who received adalimumab treatment at our dermatology and venereology clinic between January 2020 and January 2023. Medical records for complete blood count results of the patients were retrospectively reviewed. All systemic inflammation-based biomarkers were calculated from the absolute values of the complete blood count. The SII was calculated with the following formula: (neutrophil count × platelet count/lymphocyte count). The PIV was calculated as follows: (neutrophil count × platelet count × monocyte count/lymphocyte count). Values before the treatment and at the 12th week of treatment were compared.</p><p><strong>Results: </strong>When the changes in the inflammatory parameters of the patients were examined, it was found that NLR (2.13 ± 0.87 vs 2.26 ± 1.12), PLR (111.01 ± 39.89 vs 99.43 ± 35.34), MLR (0.27 ± 0.11 vs 0.28 ± 0.12), MPV (9.59 ± 0.71 vs 9.70 ± 0.79), SII (680.79 ± 330.18 vs 687.89 ± 442.66), and PIV (552.02 ± 330.71 vs 605.05 ± 415.96) values did not change statistically significantly after treatment (p > 0.05). While there was a significant decrease in platelet count compared to before treatment, no statistically significant difference was found in the other evaluated blood cells.</p><p><strong>Conclusion: </strong>Adalimumab treatment has not had a significant effect on systemic inflammation markers in HS, an inflammatory disease. More studies are needed to evaluate the effect of adalimumab on these markers in HS.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"253-257"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective cytotoxicity of standardised n-hexane extract of black soldier flies' larvae on cancerous skin cells mitochondria isolated from rat model of melanoma. 标准化正己烷提取物对从黑色素瘤大鼠模型中分离出的皮肤癌细胞线粒体的选择性细胞毒性。
IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-14 DOI: 10.1080/15569527.2024.2389193
Yalda Arast, Mahya Sabbaghi, Farzane Kamranfar, Fatemeh Heidari, Seyed Mojtaba Fazli Nejad, Tahereh Hosseinabadi, Jalal Pourahmad

Introduction: Melanoma is known as a highly lethal cancer. In melanoma cells, apoptosis signalling which relies heavily on the acute activity of mitochondria and reactive oxygen species (ROS) formation is suppressed. Our previous studies on natural compounds on melanoma suggested that mitochondria are a potential target for the melanoma treatment by selective cytotoxic effect of them. The black soldier fly is an important environmental protectant insect that based on recent studies induces apoptosis in liver and colorectal carcinoma cells through the activation of caspase 3, 8, and 9 and ultimately inhibits the growth of cancer cells.

Purpose: This study was designed to evaluate the selective apoptotic effect of the n-hexane BSFL extract (BSFLE) on skin mitochondria.

Materials and methods: The mitochondria isolated from melanoma cells were treated with various concentrations (1500, 3000, and 6000 µg/ml) of n-hexane BSFLE Then MTT viability assay, ROS determination, Mitochondrial Membrane Potential (MMP), mitochondrial swelling, cytochrome c release determination, and % apoptosis were performed.

Results: MTT assay showed that different concentrations of n-hexane BSFLE significantly (P < 0.05) decreased the SDH activity in cancerous skin mitochondria with the IC50. The ROS production and mitochondrial swelling results also showed that all concentrations of BSFL extracts significantly increased. MMP decline and the release of cytochrome c in cancer groups mitochondria. BSFLE increased apoptosis on melanoma cells.

Discussion and conclusion: It is suggested that n-hexane BSFLE compounds selectively induce a cascade of proapoptotic events that are probably defective in cancer cells. Most of these compounds target the mitochondrial transient pore caused by disruption of the mitochondrial respiratory chain. These events lead to disruption of the temporary permeability of mitochondria, swelling of mitochondria and finally the formation of apoptosome in the cytosol.

简介众所周知,黑色素瘤是一种致死率极高的癌症。黑色素瘤细胞的凋亡信号主要依赖线粒体的急性活动和活性氧(ROS)的形成。我们之前关于天然化合物对黑色素瘤的研究表明,线粒体是治疗黑色素瘤的潜在靶点,它们具有选择性细胞毒性作用。目的:本研究旨在评估正己烷 BSFL 提取物(BSFLE)对皮肤线粒体的选择性凋亡作用。材料与方法:用不同浓度(1500、3000 和 6000 µg/ml)的正己烷 BSFLE 处理从黑色素瘤细胞中分离出的线粒体,然后进行 MTT 活力测定、ROS 测定、线粒体膜电位(MMP)、线粒体肿胀、细胞色素 c 释放测定和细胞凋亡率测定:MTT 检测显示,不同浓度的正己烷 BSFLE 对癌细胞的凋亡有显著影响(P 讨论和结论:这表明正己烷 BSFLE 化合物可选择性地诱导一连串的促凋亡事件,而这些事件在癌细胞中可能是有缺陷的。这些化合物大多以线粒体瞬时孔为目标,而线粒体瞬时孔是由线粒体呼吸链的破坏引起的。这些事件导致线粒体的暂时通透性被破坏,线粒体膨胀,最后在细胞质中形成凋亡小体。
{"title":"Selective cytotoxicity of standardised n-hexane extract of black soldier flies' larvae on cancerous skin cells mitochondria isolated from rat model of melanoma.","authors":"Yalda Arast, Mahya Sabbaghi, Farzane Kamranfar, Fatemeh Heidari, Seyed Mojtaba Fazli Nejad, Tahereh Hosseinabadi, Jalal Pourahmad","doi":"10.1080/15569527.2024.2389193","DOIUrl":"10.1080/15569527.2024.2389193","url":null,"abstract":"<p><strong>Introduction: </strong>Melanoma is known as a highly lethal cancer. In melanoma cells, apoptosis signalling which relies heavily on the acute activity of mitochondria and reactive oxygen species (ROS) formation is suppressed. Our previous studies on natural compounds on melanoma suggested that mitochondria are a potential target for the melanoma treatment by selective cytotoxic effect of them. The black soldier fly is an important environmental protectant insect that based on recent studies induces apoptosis in liver and colorectal carcinoma cells through the activation of caspase 3, 8, and 9 and ultimately inhibits the growth of cancer cells.</p><p><strong>Purpose: </strong>This study was designed to evaluate the selective apoptotic effect of the n-hexane BSFL extract (BSFLE) on skin mitochondria.</p><p><strong>Materials and methods: </strong>The mitochondria isolated from melanoma cells were treated with various concentrations (1500, 3000, and 6000 µg/ml) of n-hexane BSFLE Then MTT viability assay, ROS determination, Mitochondrial Membrane Potential (MMP), mitochondrial swelling, cytochrome c release determination, and % apoptosis were performed.</p><p><strong>Results: </strong>MTT assay showed that different concentrations of n-hexane BSFLE significantly (<i>P</i> < 0.05) decreased the SDH activity in cancerous skin mitochondria with the IC50. The ROS production and mitochondrial swelling results also showed that all concentrations of BSFL extracts significantly increased. MMP decline and the release of cytochrome c in cancer groups mitochondria. BSFLE increased apoptosis on melanoma cells.</p><p><strong>Discussion and conclusion: </strong>It is suggested that n-hexane BSFLE compounds selectively induce a cascade of proapoptotic events that are probably defective in cancer cells. Most of these compounds target the mitochondrial transient pore caused by disruption of the mitochondrial respiratory chain. These events lead to disruption of the temporary permeability of mitochondria, swelling of mitochondria and finally the formation of apoptosome in the cytosol.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"264-271"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cutaneous and Ocular Toxicology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1